24-08-2026 13:29 via pharmacypracticenews.com

New Consensus Recs For Tardive Dyskinesia Focus on Long-Term Rx

Originally published by our sister publication Specialty Pharmacy ContinuumBy Gina ShawFor the first time, clinicians caring for older adults in long-term care settings have expert-developed guidance on how to screen, diagnose, and treat tardive dyskinesia (TD).“These guidelines are bringing attention to a population that has historically been underrecognized,” Swati Pradeep, DO, an assistant professor of neurology at McGovern Medical School at UTHealth Houston, told Specialty Pharma
Read more »

Pharmacy news



Safety Gains in Parenteral Nutrition, but Prescribing Gaps Persist
FDA Approves Daraxonrasib for Metastatic Pancreatic Cancer
Safety Groups Sound Alarm After FDA Compounding Panel Backs 6 of 7 Peptides
2 Measles-Associated Deaths in Pennsylvania
Student Pharmacy Phone Calls Boost Cancer Pain Management
New Phase 3 Data Show BEM/RZR Noninferior to Epclusa for Hep C
Managing IBD Patients With Few Options Left
5-Year POSITIVE Data Reassure on Pregnancy in Breast Cancer
Rethinking Iron Deficiency Anemia
Clinical Competence Is the Cornerstone of Ig Outcomes
The Value of the ACHC/IgNS Distinction in Immunoglobulin Therapy
Are We on Shaky Ground With Medication Adherence?
Targeting CD4 to Treat HIV
An Oklahoma Health System’s Road to Dual-Specialty Pharmacy Accreditation
Desktop versie